Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 31 Squamous Cell Carcinoma of Head and Neck 22 Carcinoma, Non-Small-Cell Lung 20 Breast Neoplasms 18 Neoplasms 17 Glioblastoma 17 Esophageal Squamous Cell Carcinoma 16 Rectal Neoplasms 15 Esophageal Neoplasms 15 Lung Neoplasms 14 Head and Neck Neoplasms 13 Uterine Cervical Neoplasms 11 Neoplasm Metastasis 10 Glioma 10 Oropharyngeal Neoplasms 8 Nasopharyngeal Carcinoma 8 Stomach Neoplasms 7 Radiation Injuries 7 Brain Neoplasms 7 Hyperthermia 6 Carcinoma, Hepatocellular 6 Astrocytoma 6 Urinary Bladder Neoplasms 5 Small Cell Lung Carcinoma 5 Sarcoma 5 Oligodendroglioma 5 Colorectal Neoplasms 5 Carcinoma, Renal Cell 5 Triple Negative Breast Neoplasms 4 Pancreatic Neoplasms 4

Interventions

Radiosurgery 3 Androgen Antagonists 3 pembrolizumab 1 fludrocortisone acetate 1 enzalutamide 1 darolutamide 1 cabazitaxel 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Prednisone 1 Pluvicto 1 Lutetium-177 1 Lutetium 1 Hydrocortisone 1 Gonadotropin-Releasing Hormone 1 Docetaxel 1 Dexamethasone 1 Carboplatin 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Prostate Cancer Metastatic × Radiotherapy × Clear all

NCT04983095 2026-02-17

METRO

Umeå University

Phase NA Recruiting

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡